Inactive Instrument

Press Releases OvaScience Inc OTC Bulletin Board

Equities

US69014Q1013

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

2023	Millendo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
2022	Millendo Therapeutics, Inc. and Tempest Therapeutics, Inc. Enter into First Amendment to Loan and Security Agreement	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

TEMPEST THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	21-07-23	AQ
Tempest Therapeutics : BUSINESS (Form 8-K)	21-07-16	PU
TEMPEST THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	21-07-16	AQ
Tempest Therapeutics : to Participate in William Blair 2021 Biotech Focus Conference	21-07-12	AQ
TEMPEST THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)	21-07-12	AQ
Tempest Therapeutics : to Participate in William Blair 2021 Biotech Focus Conference	21-07-09	AQ
TEMPEST THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	21-07-07	AQ
Millendo Therapeutics : Amendment to Current Report (SEC Filing - 8-K/A)	21-07-01	PU
Tempest Therapeutics : MILLENDO THERAPEUTICS, INC. Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K/A)	21-07-01	AQ
Millendo Therapeutics : Tempest Closes Merger with Millendo and Completes PIPE Financing (Form 8-K)	21-06-28	PU
Millendo Therapeutics : Tempest and Millendo Announce Stockholder Approval of Merger (Form 8-K)	21-06-23	PU
MILLENDO THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	21-06-23	AQ
MILLENDO THERAPEUTICS, INC. : Other Events (form 8-K)	21-06-11	AQ
MILLENDO THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	21-05-13	AQ
MILLENDO INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Millendo Therapeutics, Inc. - MLND	21-04-07	BU
MILLENDO THERAPEUTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	21-03-29	AQ
MILLENDO THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	21-03-29	AQ
Millendo Therapeutics : Tempest and Millendo Announce Proposed Merger Agreement	21-03-29	BU
MILLENDO THERAPEUTICS, INC. : Costs Associated with Exit or Disposal Activities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	21-01-28	AQ
MILLENDO THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	21-01-05	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases OvaScience Inc OTC Bulletin Board

Equities

US69014Q1013

Press Releases

Filters